Your browser doesn't support javascript.
loading
Safety and efficacy of an intravenous nanocrystal formulation of meloxicam in the management of moderate to severe pain following laparoscopic abdominal surgery.
Singla, Neil; McCallum, Stewart W; Mack, Randall J; Freyer, Alex; Hobson, Sue; Du, Wei.
Afiliación
  • Singla N; Lotus Clinical Research, Pasadena, CA, USA.
  • McCallum SW; Research and Development, Recro Pharma, Inc., Malvern, PA, USA, rmack@recropharma.com.
  • Mack RJ; Research and Development, Recro Pharma, Inc., Malvern, PA, USA, rmack@recropharma.com.
  • Freyer A; Research and Development, Recro Pharma, Inc., Malvern, PA, USA, rmack@recropharma.com.
  • Hobson S; Research and Development, Recro Pharma, Inc., Malvern, PA, USA, rmack@recropharma.com.
  • Du W; Clinical Statistics Consulting, Blue Bell, PA, USA.
J Pain Res ; 11: 1901-1903, 2018.
Article en En | MEDLINE | ID: mdl-30271196
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Pain Res Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Pain Res Año: 2018 Tipo del documento: Article